精密医療: 世界市場

精密医療（プレシジョンメディシン）の世界の市場規模は2023年中に542億ドル、2028年までに1,005億ドルに達し、2023年から2028年までの年平均成長率（CAGR）13.2％で成長することが予測されています。

BCC Research（BCCリサーチ）「精密医療: 世界市場 – Precision Medicine: Global Markets」は世界の精密医療（プレシジョンメディシン）市場を調査し、主要セグメント毎に行った分析・予測結果を提供します。

主な掲載内容

• イントロダクション
• サマリ＆ハイライト
• 市場概観＆定義
• 市場ダイナミクス
• 技術別精密医療（プレシジョンメディシン）市場
  • ビッグデータ分析
  • バイオインフォマティクス
  • 遺伝子シーケンス
  • 創薬
  • コンパニオン診断
• 用途別精密医療（プレシジョンメディシン）市場
  • 腫瘍学
  • 中枢神経系
  • 免疫学
  • 呼吸器疾患
• 地域別精密医療（プレシジョンメディシン）市場
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東＆アフリカ
• 新技術
• M&A
• 競争環境
• 企業情報

Report Overview

The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

Summary:

Precision medicine is a new method of illness prevention and treatment that considers a person’s unique genetic makeup, environmental factors, and lifestyle choices. According to the genetic or molecular basis of their ailments, precision medicine aims to match the proper medications or therapies to the appropriate patients. It is a method of treating patients that is based on the notion that a sickness that affects one person may not necessarily affect another person who appears to have the same condition in the same way.

No matter how simple the instruments are at their disposal, all physicians strive to improve their accuracy, precision, proactivity, and influence on each individual under their care. However, with the aid of electronic health records, genetic testing, big data analytics, and supercomputing—all the ingredients required to engage in what is quickly becoming truly precise and personalized medicine—modern doctors and scientists are now able to take this mission far, far beyond the reach of their predecessors. One of the most promising methods for combating diseases for which there are now no viable therapies or cures is precision medicine, often known as customized medicine.

Growing demand for personalized medicine, technological advancements, government initiatives, and rise in chronic disease prevalence are the major factors driving the market. However, data interpretation, data privacy, and cost are hindering the growth of the market.

The global precision medicine market was valued at nearly $REDACTED billion in 2022. The market is expected to grow at a compound annual growth rate of REDACTED% to reach $REDACTED billion by the end of 2028.

For the purposes of this report, the global market for precision medicine is segmented into technology, application, and geographical region. The precision medicine market technology types include big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. The applications for which precision medicine can be considered are oncology, central nervous system, immunology, respiratory, and other applications. Big data analytics has the major share in the global precision medicine market, valued at $REDACTED billion in 2022.

Precision oncology has the highest share of the global precision medicine market by application. The market value was $REDACTED billion in 2022, and this segment is expected to grow with a CAGR of REDACTED% during the forecast period of 2023 to 2028.

The major players include Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. Other important players include Catalent Inc., Amgen, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AbbVie Inc., and IQVIA.

There are several other smaller players in the market that have presence in the market because of their digital solutions. These companies include 2bPrecise, Fabric Genomics, Human Longevity Inc., LifeOmic Holdings LLC, and SOPHiA GENETICS.

Report Scope:

This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.

BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.

Report Synopsis

Report Includes:

• 26 tables
• A comprehensive overview and an up-to-date analysis of the global market for precision medicine
• Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global precision medicine market in USD million values, and corresponding market share analysis by technology type, application, end user, and region
• Insights into the recent industry structure for precision medicine technologies, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Review of the recent patent grants and patent applications on precision medicine technologies
• Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global precision medicine industry
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
• Detailed company profiles of the leading market players, including AstraZeneca, Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., and Johnson & Johnson

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Summary

Chapter 3 Market Overview and Definition

Definition
Overview

Chapter 4 Market Dynamics

Market Drivers
Growing Demand for Personalized Medicine
Technological Advancement
Government Initiatives
Rise in Chronic Disease Prevalence
Market Challenges
Data Interpretation
Data Privacy
Cost of Precision Medicine

Chapter 5 Precision Medicine Market by Technology

Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics

Chapter 6 Precision Medicine Market by Application

Oncology
Central Nervous System
Immunology
Respiratory Disease

Chapter 7 Precision Medicine Market by Region

North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 8 Emerging Technologies

Emerging Technology in Precision Medicine

Chapter 9 Merger and Acquisitions

Mergers and Acquisitions

Chapter 10 Competitive Intelligence

Global Company Ranking

Chapter 11 Company Profiles

2BPRECISE
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BRISTOL-MYERS SQUIBB CO.
CATALENT INC.
CLINISYS
F. HOFFMANN-LA ROCHE LTD.
FABRIC GENOMICS
HUMAN LONGEVITY INC.
IQVIA HOLDINGS INC.
JOHNSON & JOHNSON
LIFEOMIC HOLDINGS LLC
LONZA
MERCK & CO. INC.
NOVARTIS AG
PAREXEL INTERNATIONAL CORP.
PFIZER INC.
SOPHIA GENETICS
SYAPSE INC.
THERMO FISHER SCIENTIFIC INC.

List of Tables

Summary Table : Global Market for Precision Medicine, by Region, Through 2028
Table 1 : Global Market for Precision Medicine, by Technology, Through 2028
Table 2 : Global Market for Precision Medicine, by Application, Through 2028
Table 3 : Global Market for Precision Medicine, by Region, Through 2028
Table 4 : North American Market for Precision Medicine, by Country, Through 2028
Table 5 : North American Market for Precision Medicine, by Technology, Through 2028
Table 6 : North American Market for Precision Medicine, by Application, Through 2028
Table 7 : European Market for Precision Medicine, by Country, Through 2028
Table 8 : European Market for Precision Medicine, by Technology, Through 2028
Table 9 : European Market for Precision Medicine, by Application, Through 2028
Table 10 : Asia-Pacific Market for Precision Medicine, by Country, Through 2028
Table 11 : Asia-Pacific Market for Precision Medicine, by Technology, Through 2028
Table 12 : Asia-Pacific Market for Precision Medicine, by Application, Through 2028
Table 13 : South American Market for Precision Medicine, by Technology, Through 2028
Table 14 : South American Market for Precision Medicine, by Application, Through 2028
Table 15 : Middle East and African Market for Precision Medicine, by Technology, Through 2028
Table 16 : Middle East and African Market for Precision Medicine, by Application, Through 2028
Table 17 : Global Market Rankings for Precision Medicine, by Company, 2022
Table 18 : Amgen Inc.: Revenue, 2020–2022
Table 19 : AstraZeneca: Revenue, 2020–2022
Table 20 : AstraZeneca: Revenue, by Segment (Product Sales), 2020–2022
Table 21 : Bristol-Myers Squibb Co.: Revenue, 2020–2022
Table 22 : Catalent Inc.: Revenue, 2020–2022
Table 23 : Johnson & Johnson: Revenue, 2020–2022
Table 24 : Novartis AG: Revenue, 2020–2022
Table 25 : Pfizer Inc.: Revenue, 2020–2022

List of Figures

Summary Figure : Global Market for Precision Medicine, by Region, 2020-2028
Figure 1 : Global Heart and Circulatory Disease Prevalence, 2021
Figure 2 : Big Data Analytics in Personalized Medicine
Figure 3 : Outline of Precision Medicine in Oncology
Figure 4 : Common Clinical Phenotypes in Neurodegenerative and Neuropsychiatric Disorders
Figure 5 : AstraZeneca: Revenue Share, by Therapy Area, 2022
Figure 6 : AstraZeneca: Revenue Share, by Reporting Region, 2022
Figure 7 : Bristol-Myers Squibb Co.: Revenue Share, by Region, 2022
Figure 8 : Novartis AG: Revenue Share, by Region, 2022
Figure 9 : Pfizer Inc.: Revenue Share, by Country, 2022